A double-blind, randomized, placebo- and active-controlled, forced titration study evaluating the effects of nebivolol on blood pressure and heart rate in African American Patients with hypertension

Trial Profile

A double-blind, randomized, placebo- and active-controlled, forced titration study evaluating the effects of nebivolol on blood pressure and heart rate in African American Patients with hypertension

Recruiting
Phase of Trial: Phase III

Latest Information Update: 19 Nov 2005

At a glance

  • Drugs Atenolol; Nebivolol
  • Indications Hypertension
  • Focus Therapeutic Use
  • Most Recent Events

    • 19 Nov 2005 New trial record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top